Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Higuchi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Anticancer Research|January 30, 2026
Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple TherapyYasutaka Yamada, Tomoki Shirafuji, Kodai Sato, et al.
Journal of Cancer|October 2, 2023
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 StudyHirotoshi Iihara, Mototsugu Shimokawa, Hiroko Bando, et al.
Anticancer Research|May 27, 2026
Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate CancerYasutaka Yamada, Marika Matsumoto, Mai Ikehara, et al.
The Prostate|March 31, 2026
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate CancerKoichiro Kurokawa, Satoshi Yamamoto, Yasutaka Yamada, et al.
Japanese Journal of Clinical Oncology|May 17, 2025
Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center studyYosuke Kinoshita, Yasutaka Yamada, Takuya Tsujino, et al.
BJU International|November 13, 2025
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosisTomoki Shirafuji, Yasutaka Yamada, Kodai Sato, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Anticancer Research|January 30, 2026
Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple TherapyYasutaka Yamada, Tomoki Shirafuji, Kodai Sato, et al.
Journal of Cancer|October 2, 2023
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 StudyHirotoshi Iihara, Mototsugu Shimokawa, Hiroko Bando, et al.
Anticancer Research|May 27, 2026
Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate CancerYasutaka Yamada, Marika Matsumoto, Mai Ikehara, et al.
The Prostate|March 31, 2026
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate CancerKoichiro Kurokawa, Satoshi Yamamoto, Yasutaka Yamada, et al.
Japanese Journal of Clinical Oncology|May 17, 2025
Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center studyYosuke Kinoshita, Yasutaka Yamada, Takuya Tsujino, et al.
BJU International|November 13, 2025
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosisTomoki Shirafuji, Yasutaka Yamada, Kodai Sato, et al.
Pageof 2